The SBDS c.184A>T (p.Lys62*) pathogenic variant demonstrated a significant association with increased lung cancer risk, showing an odds ratio of 4.8 in case–control analysis compared to the gnomAD East Asian population [97]. This evidence concerns the gene SBDS and lung cancer.